News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lappe Mark
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/01/2023 |
4
| Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 60 shares
@ $25.0208, valued at
$1.5k
|
|
| 01/24/2023 |
4
| Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 21,665 shares
@ $25.3572, valued at
$549.4k
Sold 4,272 shares
@ $25.71, valued at
$109.8k
Sold 63 shares
@ $26.1127, valued at
$1.6k
|
|
| 01/03/2023 |
4
| Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Granted 100,000 options to buy
@ $23.3, valued at
$2.3M
|
|
| 12/20/2022 |
4
| Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 25,246 shares
@ $25.5337, valued at
$644.6k
Sold 754 shares
@ $26.2859, valued at
$19.8k
|
|
| 11/18/2022 |
4
| Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 6,959 shares
@ $25.3596, valued at
$176.5k
Sold 4,106 shares
@ $26.5703, valued at
$109.1k
Sold 4,333 shares
@ $27.4492, valued at
$118.9k
Sold 1,767 shares
@ $28.8574, valued at
$51k
Sold 6,773 shares
@ $30.1485, valued at
$204.2k
Sold 912 shares
@ $30.668, valued at
$28k
Sold 1,150 shares
@ $32.3837, valued at
$37.2k
|
|
| 10/18/2022 |
4
| Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Sold 8,981 shares
@ $28.6626, valued at
$257.4k
Sold 14,006 shares
@ $29.9245, valued at
$419.1k
Sold 2,892 shares
@ $30.8055, valued at
$89.1k
Sold 121 shares
@ $31.5071, valued at
$3.8k
|
|
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/19/2021 |
4
| Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.|
Txns:
| Gifted 500,000 shares
@ $0
Gifted 500,000 shares
@ $0
Granted 145,000 options to buy
@ $33.63, valued at
$4.9M
|
|
| 08/18/2020 |
3
| Lappe Mark (CEO) has filed a Form 3 on Inhibrx, Inc. |
| 03/17/2011 |
4
| Efficacy Capital, Ltd. (10% Owner) has filed a Form 4 on AEOLUS PHARMACEUTICALS, INC.|
Txns:
| Sold 193,234 shares
@ $0.76, valued at
$146.9k
Sold 3,799,380 shares
@ $0.61, valued at
$2.3M
Sold 2,541,000 warrants
@ $0.75, valued at
$1.9M
|
|
| 02/17/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/10/2011 |
4
| Efficacy Capital, Ltd. (10% Owner) has filed a Form 4 on AEOLUS PHARMACEUTICALS, INC.|
Txns:
| Disposed of 616,450 shares
@ $0
Disposed of 776,904 shares
@ $0
Disposed of 479,461 warrants
@ $0.75, valued at
$359.6k
Disposed of 604,258 warrants
@ $0.75, valued at
$453.2k
|
|
| 12/21/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/15/2009 |
4
| Efficacy Capital, Ltd. (10% Owner) has filed a Form 4 on REPROS THERAPEUTICS INC.|
Txns:
| Sold 126,500 shares
@ $0.696, valued at
$88k
Sold 77,900 shares
@ $0.699, valued at
$54.5k
Sold 181,700 shares
@ $0.67, valued at
$121.7k
|
|
| 12/02/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/23/2009 |
4
| Efficacy Capital, Ltd. (10% Owner) has filed a Form 4 on REPROS THERAPEUTICS INC.|
Txns:
| Sold 214,000 shares
@ $0.7487, valued at
$160.2k
Sold 215,000 shares
@ $0.7069, valued at
$152k
Sold 227,000 shares
@ $0.7013, valued at
$159.2k
|
|
| 05/22/2009 |
4
| Lappe Mark (10% Owner) has filed a Form 4 on REPROS THERAPEUTICS INC. |
|
|